EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
VistaGen Therapeutics, Inc. (VTGN) EBITDA Margin data is not available.
| Income Statement Financials | |
$0.46M |
|
$-16.27M |
|
-- |
|
$0.46M |
|
$17.19M |
|
$-16.72M |
|
$0.46M |
|
$-16.27M |
|
$-16.27M |
|
$-16.26M |
|
$-16.26M |
|
$-16.27M |
|
$-16.26M |
|
$-16.72M |
|
$-16.80M |
|
38.07M |
|
38.07M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$46.94M |
|
$0.43M |
|
$1.62M |
|
$48.56M |
|
$12.79M |
|
-- |
|
$0.25M |
|
$13.04M |
|
$35.52M |
|
$35.52M |
|
$35.52M |
|
39.62M |
|
| Cash Flow Statement Financials | |
$-66.44M |
|
$-0.88M |
|
$30.97M |
|
$67.13M |
|
$30.79M |
|
$-36.34M |
|
$4.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.67 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
100.00% |
|
-3604.09% |
|
-3604.09% |
|
|
EBITDA Margin |
-- |
-3505.82% |
|
-3507.33% |
|
$-66.59M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-45.78% |
|
-45.78% |
|
-33.48% |
|
-45.78% |
|
$0.90 |
|
$-1.75 |
|
$-1.74 |
|